| Name | Steward Organization | Suggested Domain | Suggested Domain Description | Cde Group | Classification |
|---|---|---|---|---|---|
| Genetic or chromosomal abnormalities | ADNI | Biomarkers, genetics, and genomics |
Biomarkers, genetics, and genomics relevant to AD/ADRD |
Other NIA-funded studies |
|
| # | Datatype |
|---|---|
|
|
Value List |
| # | Permissible value | Value meaning name |
|---|---|---|
|
|
1 | APP mutation |
|
|
2 | PS1 mutation |
|
|
3 | PS2 mutation |
|
|
4 | Tau mutation |
|
|
5 | alpha-Synuclein mutation |
|
|
6 | Parkin mutation |
|
|
7 | PRNP mutation |
|
|
8 | Huntingtin mutation |
|
|
9 | Notch 3 mutation (CASDASIL) |
|
|
10 | Otherknown genetic mutation (e.g., Abri, neuroserpin) |
|
|
11 | Down syndrome |
|
|
12 | Other chromosomal abnormality |
|
|
13 | No known genetic |
|
|
50 | Not assessed |
|
|
99 | Missing/unknown |
|
|
chromosomal abnormality | chromosomal abnormality |
| # | Identifier | Origin | Version |
|---|---|---|---|
|
|
NOPHASE_NACC Neuropathology Data Form_NEUROPATH_NPCHROM_NODD_CRF_VERSION | ADNI-PHASE+CRFNAME+TBLNAME+FLDNAME+DD_CRF_VERSION | ADNI_01-12-2025 |